CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Biogen Inc 's Working Capital Ratio

BIIB's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




BIIB Working Capital Ratio (Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Current Liabilities Change -23.06 % -14.17 % 7.36 % 47.32 % 47.6 %
Y / Y Current Assets Change -17.83 % -7.16 % 7.38 % -10.46 % 9.7 %
Working Capital Ratio MRQ 1.84 2.06 2.46 1.73 1.72
Overall Ranking # # # # #
Seq. Current Liabilities Change -1.62 % 10.35 % -25.69 % -4.63 % 9.74 %
Seq. Current Assets Change -12.19 % -7.66 % 6.08 % -4.47 % -0.79 %



Working Capital Ratio forth quarter 2020 Comment
Despite sequential decrease in Current Liabilities, Working Capital Ratio detoriated to 1.84 below company average Working Capital Ratio.

Within Biotechnology & Drugs industry 155 other companies have achieved higher Working Capital Ratio than Biogen Inc in forth quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is BIIB most successful ?
Working Capital Ratio BIIB on the trailing twelve month basis
Working Capital Ratio forth quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 156
Healthcare Sector # 604
Overall Market # 2112


Working Capital Ratio Statistics
High Average Low
6.13 2.62 0.78
(Dec. 31, 2005)   (June 30. 2007)




Financial Statements
Biogen Inc 's Current Liabilities $ 3,742 Millions Visit BIIB's Balance sheet
Biogen Inc 's Current Assets $ 6,887 Millions Visit BIIB's Balance sheet
Source of BIIB's Sales Visit BIIB's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingDec 31 2020, within Biotechnology & Drugs Industry Working Capital RatioDec 31 2020 MRQ Current AssetsDec 31 2020 MRQ Current Liabilities
Catalyst Biosciences Inc   5.03 $ 89.510  Millions$ 17.796  Millions
Apollo Endosurgery inc   5.02 $ 58.530  Millions$ 11.668  Millions
Neuronetics Inc   4.97 $ 65.012  Millions$ 13.088  Millions
Inhibrx Inc   4.93 $ 132.172  Millions$ 26.815  Millions
Pharmacyte Biotech Inc   4.89 $ 3.133  Millions$ 0.640  Millions
Merus N v   4.66 $ 217.993  Millions$ 46.746  Millions
Bio techne Corp  4.61 $ 541.933  Millions$ 117.568  Millions
Sangamo Therapeutics Inc   4.60 $ 659.668  Millions$ 143.547  Millions
Procyon Corp  4.38 $ 2.088  Millions$ 0.476  Millions
Cytrx Corp  4.12 $ 11.423  Millions$ 2.774  Millions
Heska Corporation  4.07 $ 171.275  Millions$ 42.115  Millions
Fulgent Genetics Inc   4.02 $ 523.616  Millions$ 130.115  Millions
Seneca Biopharma Inc   4.02 $ 12.881  Millions$ 3.206  Millions
Pulmatrix Inc   3.94 $ 32.538  Millions$ 8.254  Millions
Dbv Technologies S a   3.93 $ 207.375  Millions$ 52.713  Millions
Evelo Biosciences Inc   3.91 $ 70.980  Millions$ 18.159  Millions
Applied Genetic Technologies Corp  3.87 $ 55.177  Millions$ 14.244  Millions
Aclaris Therapeutics Inc   3.87 $ 57.493  Millions$ 14.874  Millions
Brainstorm Cell Therapeutics Inc   3.85 $ 43.242  Millions$ 11.233  Millions
Cyclo Therapeutics Inc   3.84 $ 14.050  Millions$ 3.655  Millions
Axon Enterprise inc   3.83 $ 981.952  Millions$ 256.331  Millions
Vitality Biopharma Inc   3.71 $ 1.455  Millions$ 0.392  Millions
Aytu Bioscience Inc  3.58 $ 92.537  Millions$ 25.813  Millions
Cel sci Corporation  3.46 $ 25.369  Millions$ 7.334  Millions
Windtree Therapeutics Inc  3.40 $ 18.118  Millions$ 5.326  Millions
Quidel Corp  3.39 $ 1,142.402  Millions$ 336.961  Millions
Champions Oncology Inc   3.35 $ 13.969  Millions$ 4.171  Millions
Quotient Limited  3.33 $ 167.639  Millions$ 50.409  Millions
Meridian Bioscience Inc   3.30 $ 177.616  Millions$ 53.831  Millions
Genocea Biosciences Inc   3.29 $ 82.227  Millions$ 24.995  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IDYA's Profile

Stock Price

IDYA's Financials

Business Description

Fundamentals

Charts & Quotes

IDYA's News

Suppliers

IDYA's Competitors

Customers & Markets

Economic Indicators

IDYA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071